AbC-19TM rapid antibody test performance data
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
AbC-19TM rapid antibody test performance data
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes
the press release issued today by the UK Rapid Test Consortium ("UK-RTC"), of which Omega is a partner, welcoming a pre-print publication, funded by Public Health England (PHE), reviewing performance data on rapid antibody tests including the AbC-19TM Rapid Test.
The study, performed by scientists at PHE, and the Universities of Bristol, Warwick and Cambridge, examined the performance of four lateral flow rapid antibody tests using the same cohort of sample, and shows that the AbC-19TM is highly accurate when tested on samples from individuals previously positive for the virus by PCR and from samples collected pre-pandemic.
All devices tested had accuracy of above 92% with the AbC-19 TM Rapid Test showing the highest accuracy at 97.3%. The study remains subject to peer review.
The AbC-19TM Rapid test c onfirms the presence of SARS-CoV-2 IgG neutralising antibodies to the spike protein of the COVID-19 virus in a small blood sample. These neutralizing antibodies may be produced as part of the body's immune response following COVID-19 infection or post-vaccination. They not only bind to a virus, but they bind in a manner that blocks infection.
Professor Chris Molloy, Chair of the UK-RTC, said: "This research on the different use cases for lateral flow antibody tests is welcome. The AbC-19 TM test is an important weapon in the global fight against COVID-19. It allows us to see the neutralising IgG antibodies produced in response to infection, or after vaccination."
The UK-RTC press release can be read in full here: https://www.abc19.com/
Contacts:
|
Omega Diagnostics Group PLC |
|
|
Colin King, Chief Executive |
via Walbrook PR |
|
Kieron Harbinson, Group Finance Director |
|
|
|
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
|
Geoff Nash/Edward Whiley (Corporate Finance) |
|
|
Alice Lane (ECM) |
|
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
|
Paul McManus |
Mob: 07980 541 893 |
|
Lianne Cawthorne |
Mob: 07584 391 303 |
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 6 minutes ago Associated British Foods
- 29 minutes ago Centaur Media
- 1 hour ago Wizz Air Holdings
- 1 hour ago Trifast
- 1 hour ago Molten Ventures